OXURION (EBR:OXUR) | Finanzwire

Basculer en Français

9473	Companies
185388	Keywords
117743	Articles
99274	Press releases

Home
Companies
OXURION

BRIEF

published on 10/03/2025 at 18:05, 2 months 1 day ago

Capital Increase for Oxurion Following the Conversion of Bonds

Common Shares Convertible Bonds Capital Increase Atlas Special Opportunities Oxurion
PRESS RELEASE

published on 10/03/2025 at 18:00, 2 months 1 day ago

Information on the Total Number of Voting Rights (Denominator) following Conversion Notice from Atlas
Atlas Special Opportunities, LLC converts 4 convertible bonds in Oxurion, leading to EUR 100,000 capital increase. Oxurion issues 5,990,086 new ordinary shares as part of EUR 20m Capital Commitment with Atlas. Company's total outstanding shares now 56,367,609

Shares Convertible Bonds Capital Increase Atlas Special Opportunities Oxurion
BRIEF

published on 10/02/2025 at 18:05, 2 months 2 days ago

Oxurion Receives Transparency Notification from Atlas Special Opportunities II LLC

Actions Transparency Pharmaceutical Atlas Special Opportunities Oxurion
PRESS RELEASE

published on 10/02/2025 at 18:00, 2 months 2 days ago

Oxurion Receives Transparency Notification from Atlas Special Opportunities II LLC
Oxurion NV received a transparency notification from Atlas Special Opportunities II, LLC regarding changes in shareholding. The company specializes in acquiring stakes in European pharmaceutical subcontractors. Risks associated with forward-looking statements and planned investments in digital assets are highlighted

Forward-looking Statements Digital Assets Transparency Notification Oxurion NV Pharmaceutical Subcontractors
BRIEF

published on 09/30/2025 at 18:05, 2 months 4 days ago

Oxurion 2025 Half-Year Results: Financial and Operational Analysis

Financial Results Digital Assets Forecasts Oxurion Pharmaceutical Subcontractors
PRESS RELEASE

published on 09/30/2025 at 18:00, 2 months 4 days ago

Oxurion Publishes First Half 2025 Results
Oxurion NV releases financial and business update for the six-month period ending June 30, 2025. The half-year report is available on the company's website. Oxurion specializes in acquiring pharmaceutical subcontractors

Acquisition Business Update Pharmaceutical Financial Update Oxurion NV
BRIEF

published on 09/16/2025 at 18:05, 2 months 18 days ago

Oxurion and Axiodis CRO leverage AI to revolutionize clinical trials

Artificial Intelligence Clinical Trials Oxurion Digital Twins Axiodis CRO
PRESS RELEASE

published on 09/16/2025 at 18:00, 2 months 18 days ago

Axiodis CRO, the French subsidiary of the Oxurion Group, announces a dual AI-driven strategic initiative to transform clinical trials
Axiodis CRO, a subsidiary of Oxurion NV, leverages AI to enhance clinical trials with digital twins for disease simulation and AI modules integrated into Exagis eCRF solution for improved data quality and workflow efficiency

AI Integration Clinical Trials Oxurion NV Digital Twins Axiodis CRO
BRIEF

published on 09/08/2025 at 18:05, 2 months 26 days ago

Oxurion Receives Transparency Notification from Atlas Special Opportunities II LLC

Actions Transparency Atlas Special Opportunities Financial Risks Oxurion
PRESS RELEASE

published on 09/08/2025 at 18:00, 2 months 26 days ago

Oxurion Receives Transparency Notification from Atlas Special Opportunities II LLC
Oxurion NV receives transparency notification from Atlas Special Opportunities II, LLC regarding change in shareholding. Oxurion specializes in acquiring majority stakes in European pharmaceutical subcontractors

Transparency Notification Shareholding Change Oxurion NV Belgian Transparency Legislation European Pharmaceutical Subcontractors

Accesswire

Published on 12/05/2025 at 02:35, 5 hours 50 minutes ago

Future Fuels Initates Drill Permitting at Hornby; Marketing Update
Published on 12/05/2025 at 02:30, 5 hours 55 minutes ago

Klondike Gold Announces AGM Results
Published on 12/05/2025 at 01:00, 7 hours 25 minutes ago

BEACN Closes First Tranche of Non-Brokered Private Placement
Published on 12/04/2025 at 23:05, 9 hours 20 minutes ago

BlackBerry to Announce Third Quarter Fiscal Year 2026 Results on December 18, 2025
Published on 12/04/2025 at 23:00, 9 hours 25 minutes ago

NXT Energy Solutions Completes Data Acquisition for SFD Survey

View all ACCESSWIRE

EQS Group

Published on 12/05/2025 at 08:05, 19 minutes ago

Smartmi Unveils the Air Purifier 3: Powerful, Smart, and Stylish Air Care for Modern Homes
Published on 12/05/2025 at 08:01, 23 minutes ago

Original-Research: Warimpex Finanz- und Beteiligungsholding AG (von East Value Research GmbH ):
Published on 12/05/2025 at 08:01, 23 minutes ago

Custodian Property Income REIT plc: Interim results for the period ended 30 September 2025
Published on 12/05/2025 at 08:00, 24 minutes ago

Swiss Prime Site Solutions Investment Fund Commercial (SPSS IFC) approaches the 500-million mark ahead of listing
Published on 12/05/2025 at 08:00, 24 minutes ago

Custodian Property Income REIT plc: Share Buyback

Les Echos

Published on 12/04/2025 at 18:00, 14 hours 25 minutes ago

Information concerning the total number of voting rights and shares in the share capital as of November 28, 2025
Published on 12/04/2025 at 17:45, 14 hours 40 minutes ago

MONTHLY INFORMATION RELATING TO THE TOTAL NUMBER OF VOTING RIGHTS AND SHARES MAKING UP THE SHARE CAPITAL
Published on 12/04/2025 at 17:44, 14 hours 40 minutes ago

Net profit attributable to owners of the parent up by 63% to €122 million, driven by business resilience and the improvement in Elior's contribution
Published on 12/04/2025 at 07:01, 1 day 1 hour ago

bioMérieux launches leading endocrinology testing offer dedicated to enhancing equine health
Published on 12/03/2025 at 18:00, 1 day 14 hours ago

Declaration of voting rights at the end of November 2025

View all LES ECHOS COMFI WIRE